focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDP.L Regulatory News (IDP)

  • There is currently no data for IDP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

27 Jan 2022 16:10

RNS Number : 8984Z
InnovaDerma PLC
27 January 2022
 

 

 LEI: 213800WRAP6W8VDL6B38

InnovaDerma PLC

("InnovaDerma" or the "Group")

Results of Annual General Meeting

InnovaDerma (LSE: IDP), a leading digitally focused UK beauty brand developer, is pleased to announce that at its Annual General Meeting ("AGM") held earlier today, all resolutions, were duly passed on a poll. 

AGM Resolutions

Resolutions 12 and 13 were proposed as special resolutions. All other resolutions were proposed as ordinary resolutions.  The results of the poll are set out below: 

Issued Share Capital ("ISC")

28,057,825

Votes cast (average across all resolutions)

1,824,040

% of ISC voted (average across all resolutions)

6.5%

 

RESOLUTIONS

Votes For

%

Votes Against

%

Votes Cast

Vote withheld*

% of ISC voted

1. To receive and adopt the annual accounts for the year ended 30 June 2021.

1824195

100%

0

0%

1824195

29919

6.5%

 

 

 

2. To receive and approve the director's remuneration report for the year ended 30 June 2021.

1816581

99.6%

7464

0.4%

1824045

30069

6.5%

 

 

 

3. To approve the Directors' Remuneration Policy

1816581

99.6%

7464

0.4%

1824045

30069

6.5%

 

 

4. To reappoint Crowe UK LLP as auditors of the company.

1816731

99.7%

5861

0.3%

1822592

31522

6.5%

 

 

5. To authorise the directors to fix the remuneration of the auditors.

1824195

100%

0

0%

1824195

29919

6.5%

 

 

6. To reappoint Ross Andrews as a director.

1806314

99.1%

16278

0.9%

1822592

31522

6.5%

 

7. To reappoint Mark Michael Ward as a director.

1818186

100%

0

0%

1818186

35928

6.5%

 

 

8. To reappoint Andrew Dunderdale as a director.

1817314

99.7%

5278

0.3%

1822592

31522

6.5%

 

 

9. To reappoint Blake Hughes as a director.

1812908

99.7%

5278

0.3%

1818186

35928

6.5%

 

10. To reappoint Simon Pyper as a director.

1817314

99.7%

5278

0.3%

1822592

31522

6.5%

 

11. To confer on the Directors authority to allot securities in accordance with Section 551 of the Companies Act 2006.

1809509

99.3%

13083

0.7%

1822592

31522

6.5%

 

 

 

 

12. To confer on the Directors power to allot securities under a disapplication of Section 561 of the Companies Act 2006.

1805103

99.3%

13083

0.7%

1818186

35928

6.5%

 

 

 

 

13. To authorise the Company to make market purchases of its own shares for the purposes of Sections 693 and 701 of the Companies Act 2006.

1811695

98%

36825

2%

1848520

5594

6.6%

 

 

 

 

* A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes 'For' or 'Against' a resolution.

The full text of all the resolutions can be found in the Notice of Annual General Meeting which is available for viewing from the Group's website at:  https://www.innovaderma.com/company-publications

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Further enquiries

InnovaDerma

Blake Hughes

 

c/o TB Cardew

finncap Ltd

Geoff Nash/Kate Bannatyne

Alice Lane - Corporate Broking

 

+44 (0)207 220 0500

www.finncap.com

TB Cardew

Shan Shan Willenbrock/

+ 44 (0)7775 848537

Olivia Rosser

+ 44 (0)7552 864250

innovaDerma@tbcardew.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGPPUMUGUPPGQM
Date   Source Headline
12th Jan 20227:00 amRNSTrading Update
6th Jan 20222:06 pmRNSSecond Price Monitoring Extn
6th Jan 20222:01 pmRNSPrice Monitoring Extension
4th Jan 20227:00 amRNSAcquisition of Remaining Shareholding - Skinny Tan
24th Dec 202112:44 pmRNSHolding(s) in Company
24th Dec 202112:41 pmRNSDirector/PDMR Shareholding
23rd Dec 20211:22 pmRNSNotice of AGM and Posting of Annual Report
20th Dec 20219:10 amRNSFinal Results
6th Dec 20217:00 amRNSJV established to accelerate growth of Prolong
22nd Oct 20217:00 amRNSExtension to Annual Report & Accounts Publication
12th Oct 20217:00 amRNSAppointment of Skinny Tan brand ambassador
16th Sep 202111:17 amRNSDirector/PDMR Shareholding
15th Sep 20217:00 amRNSHolding(s) in Company
13th Sep 20216:24 pmRNSHolding(s) in Company
7th Sep 202110:35 amRNSDirector/PDMR Shareholding
2nd Sep 20217:00 amRNSCorporate Update
8th Jul 20217:00 amRNSTrading Statement
5th Jul 20217:00 amRNSChange of Auditor
11th May 20216:15 pmRNSDirector/PDMR Shareholding
7th May 202111:05 amRNSSecond Price Monitoring Extn
7th May 202111:00 amRNSPrice Monitoring Extension
4th May 20215:12 pmRNSHolding(s) in Company
29th Apr 202112:24 pmRNSResult of Open Offer and General Meeting
29th Apr 20217:00 amRNSGeneral Meeting and Trading Statement
19th Apr 20214:41 pmRNSSecond Price Monitoring Extn
19th Apr 20214:35 pmRNSPrice Monitoring Extension
16th Apr 202111:00 amRNSDirector/PDMR Shareholding
12th Apr 20216:19 pmRNSPublication of Prospectus
12th Apr 20217:00 amRNSExpected Timetable of Events
31st Mar 20217:00 amRNSInterim Results
22nd Mar 20212:25 pmRNSNotice of Results, Prospectus and General Meeting
24th Feb 20215:09 pmRNSForm 8.3 - Offeree Innovaderma
24th Feb 20214:47 pmRNSForm 8.3 - InnovaDerma PLC
23rd Feb 20211:51 pmRNSForm 8.3 - InnovaDerma PLC
22nd Feb 20214:48 pmRNSForm 8.3 - Innovaderma
19th Feb 20214:13 pmRNSForm 8.3 - Innovaderma PLC
18th Feb 20217:00 amRNSForm 8.3 - InnovaDerma PLC
17th Feb 20215:23 pmRNSForm 8.3 - InnovaDerma PLC
17th Feb 202112:37 pmRNSForm 8.3 - InnovaDerma
16th Feb 20216:23 pmRNSForm 8.3 - InnovaDerma PLC
16th Feb 202112:33 pmRNSForm 8.3 - InnovaDerma
16th Feb 202110:52 amRNSForm 8.3 - Innovaderma Plc
16th Feb 202110:06 amRNSForm 8.3 - Innovaderma PLC
16th Feb 20219:05 amBUSForm 8.3 - INNOVADERMA PLC - AMENDMENT
15th Feb 20216:12 pmRNSForm 8.3 - InnovaDerma
15th Feb 20215:03 pmRNSForm 8.3 - InnovaDerma Plc
15th Feb 20215:02 pmRNSHolding(s) in Company
15th Feb 20214:47 pmRNSForm 8 (OPD) - InnovaDerma plc
15th Feb 20213:40 pmRNSForm 8.3 - InnovaDerma PLC
15th Feb 20212:54 pmRNSForm 8.3 - InnovaDerma PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.